Search by Drug Name or NDC

    NDC 60505-6148-04 Ceftriaxone Sodium 1 g/1 Details

    Ceftriaxone Sodium 1 g/1

    Ceftriaxone Sodium is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is CEFTRIAXONE SODIUM.

    Product Information

    NDC 60505-6148
    Product ID 60505-6148_0432e6c3-ad77-726c-e063-6294a90a798c
    Associated GPIs 02300090102115
    GCN Sequence Number 009162
    GCN Sequence Number Description ceftriaxone sodium VIAL 1 G INJECTION
    HIC3 W1Y
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION
    GCN 39962
    HICL Sequence Number 003996
    HICL Sequence Number Description CEFTRIAXONE SODIUM
    Brand/Generic Generic
    Proprietary Name Ceftriaxone Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ceftriaxone Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, FOR SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 1
    Active Ingredient Units g/1
    Substance Name CEFTRIAXONE SODIUM
    Labeler Name Apotex Corp.
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203702
    Listing Certified Through 2024-12-31

    Package

    NDC 60505-6148-04 (60505614804)

    NDC Package Code 60505-6148-4
    Billing NDC 60505614804
    Package 10 VIAL, SINGLE-USE in 1 CARTON (60505-6148-4) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE
    Marketing Start Date 2017-06-30
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.651
    Pricing Unit EA
    Effective Date 2024-01-17
    NDC Description CEFTRIAXONE 1 GM VIAL
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis